MUMBAI, India, Jan. 31 -- Intellectual Property India has published a patent application (202417037541 A) filed by Sawai Pharmaceutical Co. Ltd., Osaka, Japan, on May 13, 2024, for 'particle containing teneligliptin and preparation containing the particle.'
Inventor(s) include Nishimura Takuro.
The application for the patent was published on Jan. 31, under issue no. 05/2025.
According to the abstract released by the Intellectual Property India: "One problem to be addressed by an embodiment of the present invention is to provide teneligliptin-containing particles that maintain the amorphous form of teneligliptin after storage in an opened condition susceptible to the effects of humidity. Moreover, another problem to be addressed by an emb...